Recent Finacing
Recent Raise
Mythic Therapeutics develops antibody–drug conjugates using FateControl technology to enhance ADC internalization in target tissues, limit off-target payload release, and advance a lung cancer lead program from Waltham, MA.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
